Fractyl Health, Inc. Common Stock
GUTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $3 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $290 | $0 | $0 | $0 |
| Gross Profit | -$290 | $0 | $0 | $3 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $17,457 | $21,151 | $19,435 | $20,281 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,947 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $4,928 | $5,324 | $4,932 |
| Operating Expenses | $22,404 | $26,079 | $24,759 | $25,213 |
| Operating Income | -$22,694 | -$26,079 | -$24,759 | -$25,210 |
| % Margin | – | – | – | -840,333.3% |
| Other Income/Exp. Net | -$22,909 | -$1,810 | $1,024 | $240 |
| Pre-Tax Income | -$45,603 | -$27,889 | -$23,735 | -$24,970 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$45,603 | -$27,889 | -$23,735 | -$24,970 |
| % Margin | – | – | – | -832,333.3% |
| EPS | -0.71 | -0.57 | -0.49 | -0.51 |
| % Growth | -24.6% | -16.3% | 3.9% | – |
| EPS Diluted | -0.71 | -0.57 | -0.49 | -0.51 |
| Weighted Avg Shares Out | 64,653 | 49,043 | 48,865 | 48,755 |
| Weighted Avg Shares Out Dil | 64,653 | 49,043 | 48,865 | 48,755 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $226 | $503 | $726 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $290 | $270 | $290 | $223 |
| EBITDA | -$45,313 | -$25,809 | -$24,469 | -$24,987 |
| % Margin | – | – | – | -832,900% |